FDA Approval Archives

Healthcare Industry News Weekly Wrap-Up: July 7, 2023

// Biotech and Pharma Therapeutics AbbVie sends SHP2 deal back to port, following Big Pharma peer in retreating from target July 5, 2023 / Jacobio / AbbVie / Solid Tumor / Licensing Deals China-headquartered Jacobio has announced the termination of...

July 7, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: June 23, 2023

// Biotech and Pharma Therapeutics Eli Lilly’s Mounjaro is primed to overtake Novo Nordisk’s popular diabetes and obesity duo: report June 19, 2023 / Mounjaro / Eli Lilly / GlobalData / Novo Nordisk Approved in May of last year for...

June 23, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 14, 2023

// Biotech and Pharma Therapeutics VBI Vaccines pares down pipeline and staff to focus on hepatitis B programs April 4, 2023 / VBI Vaccines / Layoffs / Hepatitis B / Covid-19 The company will zero in on approved hepatitis B...

April 14, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 31, 2023

// Biotech and Pharma Therapeutics AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug March 28, 2023 / AbbVie / CytomX Therapeutics / Antibody Drug Conjugates / Emerging Biopharma AbbVie has ditched its pact...

March 31, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 10, 2023

// Biotech and Pharma Therapeutics AstraZeneca deals another blow to IL-12, dumping therapy to follow BMS, Merck KGaA out of race February 9, 2023 / AstraZeneca / Cytokines / Immuno-oncology / Solid Tumor Big Pharma involvement in IL-12 is fading...

February 10, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 3, 2023

// Biotech and Pharma Therapeutics Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug January 31, 2023 / Humira / Amgen / AbbieVie / New Drug Amgen’s drug, a so-called biosimilar named Amjevita, is...

February 3, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 30, 2022

// Biotech and Pharma Therapeutics Drug companies set sights on new Covid medicines to boost depleted arsenal December 28, 2022 / COVID / New Drug / AstrZeneca It was not that long ago that the medical community had a small...

December 30, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 23, 2022

// Biotech and Pharma Therapeutics Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M December 19, 2022 / Pfizer / RSV / LianBio / Licensing Deals Pfizer, looking to be the king in respiratory syncytial...

December 23, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 30, 2022

// Biotech and Pharma Therapeutics Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream September 20, 2023 / Roche / PeptiDream / Cancer / Bristol Myers Interest in radiopharmaceuticals has been taking off ever since Novartis won drug approval of...

September 30, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 1, 2021

// Biotech and Pharma Therapeutics Currax Pharmaceuticals Hosted Ribbon-cutting Ceremony to Mark the Opening of its Nashville Headquarters October, 2021 / ChemoCentryx / FDA / Autoimmune Disease Currax Parmaceuticals, LLC (“Currax”). a specialty biopharmaceutical company dedicated to expanding access to...

October 1, 2021

1 2 3 4

Tag: FDA Approval